Literature DB >> 21122901

Allergen immunotherapy: a practice parameter third update.

Linda Cox1, Harold Nelson, Richard Lockey, Christopher Calabria, Thomas Chacko, Ira Finegold, Michael Nelson, Richard Weber, David I Bernstein, Joann Blessing-Moore, David A Khan, David M Lang, Richard A Nicklas, John Oppenheimer, Jay M Portnoy, Christopher Randolph, Diane E Schuller, Sheldon L Spector, Stephen Tilles, Dana Wallace.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21122901     DOI: 10.1016/j.jaci.2010.09.034

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  186 in total

Review 1.  Could This Be IT? Epicutaneous, Sublingual, and Subcutaneous Immunotherapy for the Treatment of Food Allergies.

Authors:  Mary Grace Baker; Julie Wang
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-25       Impact factor: 4.806

2.  Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses.

Authors:  Ravi K Viswanathan; William W Busse
Journal:  Chest       Date:  2012-05       Impact factor: 9.410

Review 3.  Immunotherapy preparation guidelines, rules, and regulation.

Authors:  Robert E Esch; Greg A Plunkett
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

Review 4.  Allergen immunotherapy extract treatment set preparation: making a safer and higher quality product for patients.

Authors:  Michael R Nelson; Maureen M Petersen; Wayne O Wolverton; Cecilia P Mikita
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

5.  Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.

Authors:  Guy W Scadding; Moises A Calderon; Mohamed H Shamji; Aarif O Eifan; Martin Penagos; Florentina Dumitru; Michelle L Sever; Henry T Bahnson; Kaitie Lawson; Kristina M Harris; Audrey G Plough; Joy Laurienzo Panza; Tielin Qin; Noha Lim; Nadia K Tchao; Alkis Togias; Stephen R Durham
Journal:  JAMA       Date:  2017-02-14       Impact factor: 56.272

6.  Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2.

Authors:  Tolly G Epstein; Gary M Liss; Karen Murphy-Berendts; David I Bernstein
Journal:  Ann Allergy Asthma Immunol       Date:  2011-06-17       Impact factor: 6.347

7.  The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.

Authors:  Waltraud Emminger; María Dolores Hernández; Victòria Cardona; Frank Smeenk; Bodil S Fogh; Moises A Calderon; Frederic de Blay; Vibeke Backer
Journal:  Int Arch Allergy Immunol       Date:  2017-09-27       Impact factor: 2.749

8.  Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy.

Authors:  Vijaya B Joshi; Andrea Adamcakova-Dodd; Xuefang Jing; Amaraporn Wongrakpanich; Katherine N Gibson-Corley; Peter S Thorne; Aliasger K Salem
Journal:  AAPS J       Date:  2014-07-01       Impact factor: 4.009

Review 9.  Asthma Outcomes and Management During Pregnancy.

Authors:  Catherine A Bonham; Karen C Patterson; Mary E Strek
Journal:  Chest       Date:  2017-09-01       Impact factor: 9.410

Review 10.  Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.

Authors:  Charles B Smarr; Paul J Bryce; Stephen D Miller
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.